Background: Misuse of antifungal agents both in clinics and agriculture has been associated with the increased trend of antifungal resistance. In Tanzania, there is limited information regarding the magnitude of antifungal obtained over the counter. This study was therefore, conducted to determine the extent of over the counter (OTC) antifungal use and factors associated to it. Methods: This was a cross-sectional study involving patients buying antifungal agents from community pharmacies between May and July 2015 in Mwanza city, Tanzania. Data were collected by the investigator using interview guided questionnaire. Results: A total of 270 patients were enrolled and interviewed. The mean age was 30±12 years. Majority of patients (59.6%) were females. Of the 270 patients, 188 (69.3%) had dermatophytes. A total of 150 (55.6%, 95%CI 49.6-61) obtained antifungal OTC. Of 150 patients who received antifungal agents OTC, 64 (42.3%) received more than one antifungal agents compared to only 9.2% (11/120) of those with prescription (p<0.001). Clotrimazole was the commonly prescribed antifungal agent while fluconazole was mostly obtained OTC. On univariate analysis, increase in age was found to be associated with the tendency of obtaining antifungal agents over the counter (OR 1.03, 95% CI 1.008-1.05, P<0.006). Having skin fungal infections was the only predictor of obtaining antifungal agents OTC (OR 3.36, 95% CI 2.34-4.81, P<0.001). Conclusion: In Mwanza City, patients receive multiple antifungal agents over the counter and the practice is significantly more for those with skin fungal infections. There is a need for the advocacy on appropriate use of antifungal agent to reduce the associated impact of resistance development.
Introduction
Invasive life threatening fungal infections have dramatically increased in the past three decades (Hudson, 2001; Sundriyal et al., 2006) . The increased of fungal infections has been linked to increase use of the broad spectrum antibiotics, anticancer therapy and increase in prevalence of immunocompromised infections such as acquired immune deficiency syndrome (AIDS) (White et al., 1998) . The phenomenon of switching of some antifungal agents from only prescription to over-thecounter (OTC), has provided conducive environment to the misuse of the antifungal agents (Lipsky & Waters, 1999) . The misuse has been implicated in the rise of antifungal resistant strains as the result of selective pressure (Stephenson, 1997; Hudson, 2001) . Nevertheless the trends of opportunistic fungal infections have been observed to increase in recent decades from 18% (Mayanja et al., 1999 , Matee et al., 2000 to above 60% (Nweze & Ogbonnaya, 2011; Kwamin et al., 2013; dos Santos Abrantes et al., 2014) , which has resulted in the increase use of antifungal agents.
Over-the-counter drugs are the medicines that an individual can buy without a prescription. Most often, they include pain relievers, allergy medicine, or various types of heartburn relief medications. Generally, over-the-counter medicines are less potentially dangerous than prescription medicines. Self-medication, including the use of over-the-counter (OTC) medicines is a global phenomenon of public health concern (Bennadi, 2013; Schmiedl et al., 2014) . High levels of selfmedication practices with over-the-counter medicines and complementary and alternative medications have been reported in Australia, United States and Germany (Bradley & Blenkinsopp, 1996; Eisenberg et al., 1998; Hanlon et al., 2001; Beitz et al., 2004; Goh et al., 2004; MacLennan et al., 2006) . In a multi-centre study in six Latin American countries, a relatively high percentage of prescribed medicines were being dispensed without medical prescription and this was attributed to lack of access to medical care (DURG, 1997) .
Over the counter medications has the advantage of reducing health care cost. However, in addition to the fact that OTC and self-medication are the potential contributors to human pathogen resistance to antimicrobials, the adverse consequences of such practices may result in greater probability of inappropriate, incorrect, or undue therapy, missed diagnosis, delays in appropriate treatment, adverse drug reactions and increased morbidity (Lipsky & Water, 1999; Hersh et al., 2007; Bennadi, 2013; Schmiedl et al., 2014) . Worldwide studies on OTC antifungal uses are limited (Lipsky et al., 2000; Sihvo et al., 2000; Schneider et al., 2013) . In sub-Saharan Africa including Tanzania, there is inadequate data regarding the OTC practices (Truter & Graz, 2014) . According to the Tanzania national policy on prescription of medicine, antibiotic and antifungal are prescribed drugs (Mnyika & Killewo, 1991) . Therefore, this study was conducted to determine the magnitude of OTC and its associated factors among patients with fungal infections in Mwanza City, Tanzania.
Materials and Methods

Study design
This cross sectional study was conducted in Mwanza City in north-western Tanzania, from May to July 2015 and involved community pharmacies. A total of 27 randomly selected community pharmacies out of 57 were visited. In each pharmacy the first ten patients enquiring antifungal agents were recruited into the study. The study excluded all patients' relatives/friends who visited the pharmacy to purchase antifungal agents and patients below 18 years of age.
Data collection
Data were collected through face-to-face interview using a guided questionnaire. Then, each enrolled patient was privately interviewed to obtain demographic and necessary information's such as type of infections, prescription status, type of antifungal dispensed, number of antifungal dispensed and previous history of antifungal use. The diagnoses were obtained from the prescriptions. For patients without prescriptions the clinical pharmacist made the diagnosis; in case of the inconclusive diagnosis, a medical doctor was consulted.
Ethical considerations
Ethical clearance was granted by the joint Catholic University of Health and Allied Science/Bugando Medical Centre Research Ethics and Review Committee. Permission to conduct the study was sought from all community pharmacies administrations. All patients were requested to sign the written informed consent before recruitment. All patients' data were kept as confidential.
Data analysis
In this study patients were cauterized into those who obtained antifungal agents without prescription (OTC group) and those with prescriptions (prescriptions group). The data were entered and cleaned using Microsoft Excel software and analysed using STATA Version 11. Age as continuous variable was summarized using mean ± standard deviations. Categorical variables were summarized in proportions.
Step-wise logistic regression analysis was done to determine factors associated with habit of obtaining antifungal agents over the counter. A p-value of less than 0.05 was considered as statistically significant at the 95% confidence interval.
Results
Patient demographic characteristics
A total of 270 patients with fungal diseases were enrolled. The mean age of patients was 30±12 years and females accounted for the majority of patients (n=161; 59.63%). Only 27 (10%) patients had a history of previous antifungal use (Table 1) . 
Fungal diseases
The commonest fungal diseases were dermatophytoses 188(69.63%). Tinea corporis 43% (81/188), tinea pedis 25% (47/188) and tinea capitis 16% (30/188) were the common dermatophytes observed (Figure 1 ).
Figure 1: Distribution of dermatophytes among patients
Other fungal infections included vulvo-vaginal candidiasis 55 (20.37%), oral candidiasis 19 (7.04%) and systemic candidiasis 8 (2.96%). In the current study systemic candidiasis was referred to the fungal infections involving blood stream and meninges. Most of the patients with dermatophytes either received fluconazole 46 (24.47%) or the combination of fluconazole+clotrimazole 22 (11.7%), while for vulvo-vaginal candidiasis most of the patients received clotrimazole 52 (94.55%). All patients with oral candidiasis received nystatin (Table 2 ). Other antifungal drugs dispensed included Itraconazole capsules, Miconazole cream, Tioconazole, Salicylic acid and Benzoic acid. Clotrimazole, fluconazole, ketoconazole and griseofulvin were commonly obtained OTC (Table 3) . Out of 150 patients who received antifungal agents OTC, 64 (42.3%) received more than one antifungal agents compared to only 9.2% (11/120) of those with prescription (p<0.001). 
Predictors of OTC
The mean age of patients with prescription was 27.4±12.6 years while the mean age of patients obtained antifungal agents OTC was 31.3±10.4 years p=0.006. On univariate analysis, as the age increased by one year there was 3% chance of obtaining antifungal over the counter (OR 1.03, 95% CI 1.008-1.05, P<0.007). More males (65.4%) than females (49%) obtained antifungal OTC (OR 1.9 95% CI 1.17-3.1, p=0.01). All 27 patients with history of prior-use of antifungal agents were in the group of the OTC. Having skin fungal infections was the predictor of obtaining antifungal agents OTC (OR 3.36, 95% CI 2.34-4.81, P<0.001) ( Table 4) . 
Discussion
Availability of the antimicrobial agents OTC has been associated with the constant exposure of the pathogens to antimicrobial pressure which results to the increased antimicrobial resistance (Hudson, 2001 ). In the current study over half of the patients received antifungal agents OTC. The observed OTC practice is higher than that reported in a study in Jordan (Yousef et al., 2008) . Self-medication has been described to be common in low-and-middle income countries (Greenhalgh, 1987; Van der Geest, 1987 , 1990 Bezold, 1990) where health services are inadequate and poverty is common (Van der Geest & Hardon, 1990 ). The common drawbacks of self-medication is the delay of making definitive diagnosis that can lead to delay in obtaining appropriate therapy, use of suboptimal therapy and misuse of the antifungal agents which include inappropriate combination of antifungal agents (Ferris et al., 2002; Francis et al., 2005) . In the current study, four in every ten patients who received antifungal OTC had combination of topical and systemic antifungal agents. This is associated with the alter of the normal microbial flora and change the pattern of fungal infections (Hudson, 2001 ). In the current study all patients with previous use of antifungal agents received drug OTC. The fact that most of the patients with prior history of antifungal use tended to obtain the subsequent doses OTC has also been reported elsewhere (Wood & Brass, 2001 ). According to Ferris et al. (1996) only about one-third of patients with previous diagnosis of fungal infections could accurately diagnose a recurrent fungal infection; therefore, in about two third the subsequent treatment is inappropriate.
Azole agents are the major antifungal drugs used in the treatment of fungal infections worldwide. The emergence of azole resistant strains of fungi poses a great challenge in managing these fungal diseases (Bader et al., 2013; Mushi et al., 2016) . In this study about two-thirds of the patients received azole antifungal agents OTC. The observed prevalence in our study is much higher than that reported previously by Mathema et al. (2001) . The difference could be explained by the poor health seeking behaviour and lack of skin specialists in our setting. The use of topical antifungal agents is advocated to be under physician supervision to avoid suboptimal dosage and recurrence (Sutcliffe, 1998 ). In the current study having dermatophytes was found as predictor of obtaining antifungal agents OTC.
In conclusion, over the counter antifungal agent dispensing is high in Mwanza City and most of patients get combination antifungal therapy. Having skin fungal infections was found to predict the OTC practice. There is a need of re-enforcing the policy of antifungal prescription in Tanzania so as to reduce the consequence of antifungal misuse.
